ADHD Medicine Shortage Affects Users
Patients suffering from attention-deficit hyperactivity disorder (ADHD) are having a hard time in the US, because of a shortage in medicines used to treat ADHD. Affected drugs include Adderall XR and generic versions of popular ADHD medicines.
The shortage is due to greater demand and stricter regulation of amphetamine by the Drug Enforcement Administration (DEA). Amphetamine is the active ingredient in some ADHD drugs.
School students with ADHD are particularly affected by the shortage because it could affect their academic performance. Lack of medicine can also cause behavioral problems at school. ADHD patients could be hit financially too if their insurance company does not cover the cost of substitute ADHD drugs.
The drugs cease to be effective if the patient stops taking them. Thus, cutting back on doses can affect patients’ improvement.